You will not be allowed to compare more than 4 products at a time
View compareDescription
UrgoTul
Acute and chronic wounds with low exudate in the granulation or re-epithelialisation phase.
• Healing in a moist environment.
• Atraumatic and painless removal.
• Stimulates fibroblast proliferation.
• Very flexible.
UrgoTul is indicated for the treatment of acute wounds (burns, abrasions, traumatic wounds, post-operative wounds, etc.) and chronic wounds (venous ulcers, pressure ulcers, diabetic foot ulcers) in the epithelialisation or granulation phase, and for the treatment of wounds caused by epidermolysis bullosa.
UrgoTul is available in packs containing individually packaged sterile dressings, ready for use.
Composition
UrgoTul is a non-adhesive, non-occlusive, non-adherent lipid-colloid dressing for wounds, consisting of a polyester mesh impregnated with hydrocolloid particles (Carboxymethylcellulose CMC) and petroleum jelly.
Sterilisation Method
Radio-sterilisation.
Properties
Lipid-Colloid Technology (TLC) is a healing and gelling matrix, an exclusive and patented innovation by Urgo Laboratories.
Its specificity depends on the polymeric matrix that ensures cohesion between the hydrocolloid particles and petroleum jelly in a polyester mesh.
Upon contact with wound exudate, the hydrocolloid particles (CMC) gel and, in combination with the matrix, form a lipid-colloid film that allows:
• the maintenance of a moist environment favourable for healing;
• the stimulation of fibroblast proliferation.
UrgoTul has a greasy composition, without feeling greasy to the touch.
It does not adhere to the wound or the surrounding skin.
Dressing removal is painless for the patient and atraumatic for regenerating tissues.
Instructions for use
Wound preparation
• Clean the wound with saline solution. If an antiseptic is used first, rinse the wound thoroughly with saline solution before applying UrgoTul.
• Carefully dry the surrounding skin.
• UrgoTul can be cut using sterile scissors to adapt the dressing to the wound.
Dressing application
• Remove the protective tabs and apply UrgoTul to the wound.
• Cover UrgoTul with a secondary dressing and secure it with appropriate bandaging.
• Apply a compression bandage if prescribed.
Dressing change
• Change the dressing every 2-4 days (every 1-3 days for patients with epidermolysis bullosa). UrgoTul can be left in place for up to 7 days depending on the wound's evolution.
Precautions
• The sterile packaging must be intact before use. Do not use if the sterile packaging is damaged.
• If clinical signs of local infection are observed, treatment may be replaced with an antibacterial dressing (UrgoTul Ag/Silver, UrgoCell Ag), as per medical advice.
• In the case of deep wounds or fistulas, a part of the UrgoTul dressing must be left visible to allow for easy removal.
• Single-use individual packs: re-using a single-use dressing may expose to the risk of infection.
• Do not re-sterilise.
Status
Medical device, class IIb.
Acute and chronic wounds with low exudate in the granulation or re-epithelialisation phase.
• Healing in a moist environment.
• Atraumatic and painless removal.
• Stimulates fibroblast proliferation.
• Very flexible.
UrgoTul is indicated for the treatment of acute wounds (burns, abrasions, traumatic wounds, post-operative wounds, etc.) and chronic wounds (venous ulcers, pressure ulcers, diabetic foot ulcers) in the epithelialisation or granulation phase, and for the treatment of wounds caused by epidermolysis bullosa.
UrgoTul is available in packs containing individually packaged sterile dressings, ready for use.
| Dimensions | Units | Product Code | BND Code | BD/RDM |
| 10x12 cm 10x12 cm 15x20 cm 15x20 cm |
3 10 3 10 |
550015 550016 550017 550018 |
M040404 M040404 M040404 M040404 |
287731/R 287731/R 287731/R 287731/R |
Composition
UrgoTul is a non-adhesive, non-occlusive, non-adherent lipid-colloid dressing for wounds, consisting of a polyester mesh impregnated with hydrocolloid particles (Carboxymethylcellulose CMC) and petroleum jelly.
Sterilisation Method
Radio-sterilisation.
Properties
Lipid-Colloid Technology (TLC) is a healing and gelling matrix, an exclusive and patented innovation by Urgo Laboratories.
Its specificity depends on the polymeric matrix that ensures cohesion between the hydrocolloid particles and petroleum jelly in a polyester mesh.
Upon contact with wound exudate, the hydrocolloid particles (CMC) gel and, in combination with the matrix, form a lipid-colloid film that allows:
• the maintenance of a moist environment favourable for healing;
• the stimulation of fibroblast proliferation.
UrgoTul has a greasy composition, without feeling greasy to the touch.
It does not adhere to the wound or the surrounding skin.
Dressing removal is painless for the patient and atraumatic for regenerating tissues.
Instructions for use
Wound preparation
• Clean the wound with saline solution. If an antiseptic is used first, rinse the wound thoroughly with saline solution before applying UrgoTul.
• Carefully dry the surrounding skin.
• UrgoTul can be cut using sterile scissors to adapt the dressing to the wound.
Dressing application
• Remove the protective tabs and apply UrgoTul to the wound.
• Cover UrgoTul with a secondary dressing and secure it with appropriate bandaging.
• Apply a compression bandage if prescribed.
Dressing change
• Change the dressing every 2-4 days (every 1-3 days for patients with epidermolysis bullosa). UrgoTul can be left in place for up to 7 days depending on the wound's evolution.
Precautions
• The sterile packaging must be intact before use. Do not use if the sterile packaging is damaged.
• If clinical signs of local infection are observed, treatment may be replaced with an antibacterial dressing (UrgoTul Ag/Silver, UrgoCell Ag), as per medical advice.
• In the case of deep wounds or fistulas, a part of the UrgoTul dressing must be left visible to allow for easy removal.
• Single-use individual packs: re-using a single-use dressing may expose to the risk of infection.
• Do not re-sterilise.
Status
Medical device, class IIb.

